CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Arrow Generiques against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 29, 2023
Rapamycin Derivative For Treating Pancreas CancerNOVARTISJun 1, 2020
Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated AngiogenesisNOVARTISFeb 24, 2020

Top competitors of Arrow Generiques

Top competitors of Arrow Generiques based on patent oppositions.